TM Bioscience signs distribution agreement with Gamidor in Israel
Tm Bioscience Corporation, an emerging leader in the commercial genetic testing market, has signed a distribution agreement with Gamidor Diagnostics (Petach Tikva, Israel), a leading distributor of clinical diagnostics in Israel. Under the agreement, Gamidor will have exclusive rights to distribute the Tag-It(TM) menu of genetic tests in Israel for a minimum three-year term that can be extended annually. As Tm launches new products, they can be rolled in to the agreement upon approval of both parties.
"Gamidor, like Tm, is committed to providing its customers with the most advanced and accurate diagnostic technology available," said Greg Hines, President and CEO of Tm Bioscience. "They are the ideal partners to enable Tm to penetrate a major market for our products beyond North America." Gamidor distributes products in Israel for the world's largest suppliers of clinical diagnostics, including Perkin Elmer Life Sciences and Dade Behring.
"The market for genetic tests is well established in Israel and we anticipate tests from Tm, in particular their Cystic Fibrosis gene test and Ashkenazi Jewish Panel, will be well received," said Yacob Ofer, CEO of Gamidor Diagnostics. "These will be important products to showcase Gamidor's leadership role as a provider of cutting edge diagnostic products."
Other news from the department business & finance
